Structural and Functional Characterization of RNA polymerase and its Regulators from Mycobacterium tuberculosis and Clostridioides difficile
结核分枝杆菌和艰难梭菌 RNA 聚合酶及其调节剂的结构和功能表征
基本信息
- 批准号:10388936
- 负责人:
- 金额:$ 5.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:Actinobacteria classAnaerobic BacteriaAntibioticsBacteriaBacterial RNABiochemicalBiologyCenters for Disease Control and Prevention (U.S.)Clostridium difficileCollaborationsComplexCryoelectron MicroscopyCrystallizationCrystallographyDNA-Directed RNA PolymeraseDevelopmentEnzymesFDA approvedFamilyFirmicutesFundingGenetic TranscriptionGenomicsGenus MycobacteriumGrantGrowthHealthInfectionLeadMycobacterium smegmatisMycobacterium tuberculosisNitric OxidePopulationReactive Oxygen SpeciesResearchResistanceResolutionRifamycinsRoleStressStructureTherapeuticTranscription InitiationTranscription ProcessTuberculosisVirulenceWorkantibiotic toleranceantimicrobialbacterial resistancedrug developmentexperimental studyin vivoinsightinterdisciplinary approachmacrophagenovel therapeuticsopportunistic pathogenpathogenic bacteriaresponsetranscription factortuberculosis treatment
项目摘要
Project Summary
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), continues to pose a major health problem.
The Center for Disease Control estimates that approximately 1/3 to 1/4 of the world’s population is latently
infected. RNA polymerase (RNAP), the enzyme responsible for all transcription in bacteria, is the target for the
Rifamycin (Rif) class of antibiotics, a first line therapeutic treatment for TB. RNAP is thus a proven and
attractive target for the development of new drugs. This highlights the importance of our recent structural and
functional characterization of Mtb RNAP and the roles of two essential transcription factors required for full
transcriptional activity. The previous grant enabled us to provide a 2.8 Å resolution crystal structure of an
RNAP transcription initiation complex (TIC) from M. smegmatis and more recently cryo-EM structures of Mtb
transcription complexes. In this proposal, cryo-EM will be used to examine RNAP complexes as a starting point
to elucidate the mechanisms of a family of relatively uncharacterized transcription factors, the WhiB factors.
The WhiB factors are only found in Actinobacteria and have roles in Mtb that include essentiality for growth and
division, and responses to host induced stresses including antibiotic tolerance, nitric oxide, macrophage
invasion and reactive oxygen species. We will use a multidisciplinary approach that includes structural,
biochemical, genomic and in vivo experiments (in collaboration with J. Rock) to understand the roles and
mechanism of this important, but relatively uncharacterized family of transcription factors. The results from the
aims here have the potential to not only elucidate the mechanism and biology of these factors, but also provide
a platform for new targets for clade-specific antibiotic development and serve to guide us on how to increase
the efficacy of the current repertoire of antibiotics.
The results from the previous funding period have led to high resolution structures of Mycobacteria RNAP (by
cryo-EM and crystallography), and provided the opportunity to characterize how Rif and Rif derivatives that
inhibit Rif resistant (RifR) bacteria inhibit Mycobacteria RNAP. Here we propose to continue this line of research
with structurally uncharacterized Rif derivatives, provided by S. Brady, that inhibit additional RifR Mtb RNAPs.
Clostrioides difficile (Cdiff), a Gram-positive, sporulating, anaerobic bacterium, is an opportunistic pathogen
which is deadly to compromised hosts. Fidaxomicin (Fdx), the only other FDA approved antibiotic which targets
RNAP, is a powerful treatment for Cdiff infection. Our recent work established that Fdx can inhibit Mtb RNAP
potently, but that potency is dependent on the Actinobacteria-specific transcription factor RpbA, which is
absent in Cdiff. Here we propose to extend our expertise in biochemical and structural studies of bacterial
RNAPs to include the previously uncharacterized clade of Firmicutes to which Cdiff belongs. The results here
will elucidate the structural and biochemical basis for Fdx potency as well as provide a structural and
biochemical basis for exploiting Cdiff RNAP for drug development and optimization.
项目概要
由结核分枝杆菌 (Mtb) 引起的结核病 (TB) 仍然是一个重大的健康问题。
美国疾病控制中心估计,世界上大约 1/3 至 1/4 的人口处于潜伏状态。
RNA聚合酶(RNAP)是细菌中负责所有转录的酶,是感染的目标。
因此,利福霉素 (Rif) 类抗生素是 RNAP 的一线治疗方法,是一种经过验证的治疗方法。
开发新药的有吸引力的目标这凸显了我们最近结构和研究的重要性。
Mtb RNAP 的功能特征以及完整所需的两个必需转录因子的作用
之前的资助使我们能够提供 2.8 Å 分辨率的晶体结构。
来自耻垢分枝杆菌的 RNAP 转录起始复合物 (TIC) 以及最近 Mtb 的冷冻电镜结构
在本提案中,冷冻电镜将用于检查 RNAP 复合物作为起点。
阐明相对未表征的转录因子家族 WhiB 因子的机制。
WhiB 因子仅存在于放线菌中,并且在结核分枝杆菌中发挥作用,包括生长和生长的必要性。
分裂以及对宿主诱导的应激的反应,包括抗生素耐受性、一氧化氮、巨噬细胞
我们将使用多学科方法,包括结构、
生物化学、基因组和体内实验(与 J. Rock 合作)以了解其作用和
这个重要但相对未知的转录因子家族的机制。
这里的目标不仅有可能阐明这些因素的机制和生物学,而且还提供
一个针对分支特异性抗生素开发新目标的平台,并指导我们如何增加
目前抗生素的功效。
上一资助期的结果已导致分枝杆菌 RNAP 的高分辨率结构(由
冷冻电镜和晶体学),并提供了描述 Rif 和 Rif 衍生物如何
抑制 Rif 抗性 (RifR) 细菌抑制分枝杆菌 RNAP 在此我们建议继续这一研究方向。
具有结构未表征的 Rif 衍生物,由 S. Brady 提供,可抑制额外的 RifR Mtb RNAP。
艰难梭菌 (Cdiff) 是一种革兰氏阳性、产孢子、厌氧细菌,是一种机会性病原体
Fidaxomicin (Fdx) 是 FDA 批准的唯一一种针对受损宿主的抗生素。
RNAP 是治疗 Cdiff 感染的有效方法,我们最近的研究表明 Fdx 可以抑制 Mtb RNAP。
有效,但这种效力取决于放线菌特异性转录因子 RpbA,它是
在这里,我们建议扩展我们在细菌生化和结构研究方面的专业知识。
RNAP 包括 Cdiff 所属的先前未表征的厚壁菌分支。
将阐明 Fdx 效力的结构和生化基础,并提供结构和
利用 Cdiff RNAP 进行药物开发和优化的生化基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELIZABETH A CAMPBELL其他文献
ELIZABETH A CAMPBELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELIZABETH A CAMPBELL', 18)}}的其他基金
Structure, function, and inhibition of the SARS-CoV-2 replication-transcription complex
SARS-CoV-2 复制转录复合物的结构、功能和抑制
- 批准号:
10463632 - 财政年份:2021
- 资助金额:
$ 5.36万 - 项目类别:
Structure, function, and inhibition of the SARS-CoV-2 replication-transcription complex
SARS-CoV-2 复制转录复合物的结构、功能和抑制
- 批准号:
10669076 - 财政年份:2021
- 资助金额:
$ 5.36万 - 项目类别:
Structure, function, and inhibition of the SARS-CoV-2 replication-transcription complex
SARS-CoV-2 复制转录复合物的结构、功能和抑制
- 批准号:
10238209 - 财政年份:2021
- 资助金额:
$ 5.36万 - 项目类别:
Structural and Functional Characterization of RNA polymerase and its Regulators from Mycobacterium tuberculosis and Clostridioides difficile
结核分枝杆菌和艰难梭菌 RNA 聚合酶及其调节剂的结构和功能表征
- 批准号:
10581925 - 财政年份:2015
- 资助金额:
$ 5.36万 - 项目类别:
Structural and Functional Characterization of RNA polymerase and its Regulators from Mycobacterium tuberculosis and Clostridioides difficile
结核分枝杆菌和艰难梭菌 RNA 聚合酶及其调节剂的结构和功能表征
- 批准号:
10370352 - 财政年份:2015
- 资助金额:
$ 5.36万 - 项目类别:
Structural and Functional Characterization of RNA polymerase and its Regulators from Mycobacterium tuberculosis and Clostridioides difficile
结核分枝杆菌和艰难梭菌 RNA 聚合酶及其调节剂的结构和功能表征
- 批准号:
10586042 - 财政年份:2015
- 资助金额:
$ 5.36万 - 项目类别:
Structure/function analyses of essential mycobacterial transcription regulators
分枝杆菌必需转录调节因子的结构/功能分析
- 批准号:
8861934 - 财政年份:2015
- 资助金额:
$ 5.36万 - 项目类别:
Structure/function analyses of essential mycobacterial transcription regulators
分枝杆菌必需转录调节因子的结构/功能分析
- 批准号:
9041636 - 财政年份:2015
- 资助金额:
$ 5.36万 - 项目类别:
STRUCTURE OF THE BACTERIAL RNA POLYMERASE PROMOTER
细菌RNA聚合酶启动子的结构
- 批准号:
6975789 - 财政年份:2004
- 资助金额:
$ 5.36万 - 项目类别:
相似国自然基金
厌氧菌藻生物膜降解噻唑化合物的氢营养代谢机理研究
- 批准号:52300043
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠道厌氧菌产新颖鞘磺脂及其免疫调节活性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微氧环境下兼性厌氧菌和产甲烷菌降解长链脂肪酸的协同机制
- 批准号:52170037
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
兼性厌氧菌JPG1在不同氧条件下对铜胁迫的抗性机制与调控
- 批准号:52070037
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
肠道厌氧菌S.Moorei通过抑制AGK调节浸润性CD8+T细胞糖酵解增强直肠癌的辐射抵抗及机制
- 批准号:82073329
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Structural and Functional Characterization of RNA polymerase and its Regulators from Mycobacterium tuberculosis and Clostridioides difficile
结核分枝杆菌和艰难梭菌 RNA 聚合酶及其调节剂的结构和功能表征
- 批准号:
10581925 - 财政年份:2015
- 资助金额:
$ 5.36万 - 项目类别:
Structural and Functional Characterization of RNA polymerase and its Regulators from Mycobacterium tuberculosis and Clostridioides difficile
结核分枝杆菌和艰难梭菌 RNA 聚合酶及其调节剂的结构和功能表征
- 批准号:
10370352 - 财政年份:2015
- 资助金额:
$ 5.36万 - 项目类别:
Structural and Functional Characterization of RNA polymerase and its Regulators from Mycobacterium tuberculosis and Clostridioides difficile
结核分枝杆菌和艰难梭菌 RNA 聚合酶及其调节剂的结构和功能表征
- 批准号:
10586042 - 财政年份:2015
- 资助金额:
$ 5.36万 - 项目类别:
Selective agents against C. difficile infection
针对艰难梭菌感染的选择性药物
- 批准号:
8842587 - 财政年份:2014
- 资助金额:
$ 5.36万 - 项目类别:
Selective agents against C. difficile infection
针对艰难梭菌感染的选择性药物
- 批准号:
8842587 - 财政年份:2014
- 资助金额:
$ 5.36万 - 项目类别: